Spinal-Specific Super Enhancer in Neuropathic Pain.

Area of Science:

• Neuroscience
• Molecular Biology
• Pain Research

Background:

• Dysfunctional gene expression in nociceptive pathways is key to neuropathic pain.
• Super enhancers (SEs) regulate gene expression, but their role in pain is unknown.

Purpose of the Study:

• To investigate the role of SEs in chronic constriction injury (CCI)-induced neuropathic pain.
• To identify specific SEs and their target genes involved in pain signaling.

Main Methods:

• Identified a spinal-specific SE (SS-SE) regulating Ntmt1 and Prrx2 in dorsal horn neurons.
• Utilized bromodomain-containing protein 4 (BRD4) inhibition (JQ1) and CRISPR-Cas9 for SE deletion.
• Assessed gene expression (NTMT1, PRRX2, p-ERK, GFAP) and pain behaviors in mouse models.

Main Results:

• CCI enhanced SS-SE activity and NTMT1/PRRX2 expression in a BRD4-dependent manner.
• BRD4 inhibition and SS-SE deletion attenuated hypersensitivity and normalized gene expression.
• Knockdown of Ntmt1 or Prrx2, or their mimicry in naive mice, altered pain behaviors.

Conclusions:

• BRD4-driven SS-SE activity in dorsal horn neurons drives neuropathic pain via Ntmt1/Prrx2.
• Targeting SS-SE or BRD4 offers a novel therapeutic strategy for neuropathic pain.
• This study redefines understanding of pain-related gene regulation.